Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label …
M O'Ryan, AS Bandyopadhyay, R Villena… - The Lancet Infectious …, 2015 - thelancet.com
Background Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace
trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one …
trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one …
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin …
Background Replacement of the trivalent oral poliovirus vaccine (tOPV) with bivalent types 1
and 3 oral poliovirus vaccine (bOPV) and global introduction of inactivated poliovirus …
and 3 oral poliovirus vaccine (bOPV) and global introduction of inactivated poliovirus …
Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial
X Sáez-Llorens, R Clemens… - The Lancet Infectious …, 2016 - thelancet.com
Background Following the proposed worldwide switch from trivalent oral poliovirus vaccine
(tOPV) to bivalent types 1 and 3 OPV (bOPV) in 2016, inactivated poliovirus vaccine (IPV) …
(tOPV) to bivalent types 1 and 3 OPV (bOPV) in 2016, inactivated poliovirus vaccine (IPV) …
Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label …
H He, Y Wang, X Deng, C Yue, X Tang, Y Li… - The Lancet Infectious …, 2020 - thelancet.com
Background The globally synchronised introduction of inactivated poliovirus vaccine (IPV)
and replacement of trivalent oral poliovirus vaccine (OPV) with bivalent OPV (bOPV) were …
and replacement of trivalent oral poliovirus vaccine (OPV) with bivalent OPV (bOPV) were …
Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants
EJ Asturias, EL Dueger, SB Omer… - The Journal of …, 2007 - academic.oup.com
Background. The immunogenicity of inactivated poliovirus vaccine (IPV) in developing
countries is not well documented. This study compared the immune response to IPV with …
countries is not well documented. This study compared the immune response to IPV with …
[HTML][HTML] Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants
PF Wright, RI Connor, WF Wieland-Alter… - The Lancet infectious …, 2016 - thelancet.com
Background Identification of mechanisms that limit poliovirus replication is crucial for
informing decisions aimed at global polio eradication. Studies of mucosal immunity induced …
informing decisions aimed at global polio eradication. Studies of mucosal immunity induced …
Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis
TR Mashunye, DE Ndwandwe, KR Dube… - The Lancet Infectious …, 2021 - thelancet.com
Background Since WHO recommended introduction of at least a single dose of inactivated
poliovirus vaccine (IPV) in routine immunisation schedules, there have been global IPV …
poliovirus vaccine (IPV) in routine immunisation schedules, there have been global IPV …
[HTML][HTML] Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non …
AS Bandyopadhyay, C Gast, L Rivera… - The Lancet Infectious …, 2021 - thelancet.com
Background Following the global eradication of wild poliovirus, countries using live
attenuated oral poliovirus vaccines will transition to exclusive use of inactivated poliovirus …
attenuated oral poliovirus vaccines will transition to exclusive use of inactivated poliovirus …
[HTML][HTML] Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and …
X Sáez-Llorens, AS Bandyopadhyay, C Gast… - The Lancet, 2021 - thelancet.com
Background Continued emergence and spread of circulating vaccine-derived type 2
polioviruses and vaccine-associated paralytic poliomyelitis from Sabin oral poliovirus …
polioviruses and vaccine-associated paralytic poliomyelitis from Sabin oral poliovirus …
Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label …
Background The provision of several doses of monovalent type 1 oral poliovirus vaccine
(mOPV1) and bivalent OPV1 and 3 (bOPV) vaccines through campaigns is essential to stop …
(mOPV1) and bivalent OPV1 and 3 (bOPV) vaccines through campaigns is essential to stop …
相关搜索
- meta analysis poliovirus vaccine
- sequential schedules poliovirus vaccine
- sequential schedules open label
- open label poliovirus vaccine
- sequential schedule chilean infants
- chilean infants poliovirus vaccine
- immunogenicity and safety vaccine in infants
- immunogenicity and effectiveness poliovirus vaccine
- monovalent type poliovirus vaccine
- fractional dose poliovirus vaccine
- routine immunization poliovirus vaccine
- open label analysis of cohorts
- open label mucosal immunity
- poliovirus type vaccine in infants
- safety and immunogenicity poliovirus vaccine